[{"id":"b3fcc71c-45ea-43d9-8804-7feab6152f22","acronym":"SARMET","url":"https://clinicaltrials.gov/study/NCT01391533","created_at":"2021-01-18T05:42:43.337Z","updated_at":"2024-07-02T16:37:32.819Z","phase":"Phase 1","brief_title":"Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors","source_id_and_acronym":"NCT01391533 - SARMET","lead_sponsor":"Sanofi","biomarkers":" MET","pipe":" | ","alterations":" MET amplification • MET expression • MET positive","tags":["MET"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MET amplification • MET expression • MET positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SAR 125844"],"overall_status":"Completed","enrollment":" Enrollment 72","initiation":"Initiation: 07/01/2011","start_date":" 07/01/2011","primary_txt":" Primary completion: 04/01/2016","primary_completion_date":" 04/01/2016","study_txt":" Completion: 04/01/2016","study_completion_date":" 04/01/2016","last_update_posted":"2016-04-13"}]